National Repository of Grey Literature 2 records found  Search took 0.00 seconds. 
Access to medicines in the patent system
Borunský, Jan ; Dobřichovský, Tomáš (referee)
Access to medicines in the patent system Abstract This rigorous thesis deals with the issue of access to medicines in the patent system. In the introduction to the rigorous thesis I set several goals, which I focused on in the thesis. The first goal is to assess whether access to medicines is guaranteed at the international level, alternatively through which rights it can be deduced. Another aim is to point out possible shortcomings of the patent system in the pharmaceutical industry and to assess the suitability of alternative systems. In the final chapter I deal with the access to medicines during the current pandemic within the European Union and in developing and least-developed countries. This rigorous thesis is divided into six chapters except for the introduction and conclusion. The individual chapters logically follow each other, with the first chapter dealing with the very concept of patent and its historical development. In the second chapter, I deal with one of the goals of this rigorous thesis, whether access to medicines is guaranteed by some of the internationally recognized agreements. The third chapter is the core of the rigorous thesis, which is why it is the most comprehensive one. This chapter provides a detailed analysis of the TRIPS Agreement with particular emphasis on the individual...
Trade Related Aspects of Patent Protection in Pharmaceuticals
Trojanová, Kamila ; Štěrbová, Ludmila (advisor) ; Machková, Hana (referee)
The purpose of my thesis is to analyse the trade-related aspects of patent protection in pharmaceuticals. The first part focuses on the international regulation of patent protection and its impact on conducting business in the pharmaceutical industry. Chapter Two addresses the issue of relevant trade-related aspects - patent duration, parallel imports and compulsory licence. It describes the impact of patent protection on the generic pharmaceutical industry. Chapter Three concentrates on the attitudes of the pharmaceutical industry and governments, especially those of developing countries. It examines the progress within the World Trade Organization (WTO).

Interested in being notified about new results for this query?
Subscribe to the RSS feed.